Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: Synthesis, characterisation and preliminary evaluation of biological activity
文献类型：期刊论文
| 作者 | Ji, Liyun1,2; Zheng, Wei1,2; Lin, Yu1,2; Wang, Xiuli3; Lu, Shuang1,2; Hao, Xiang1,2; Luo, Qun1,2; Li, Xianchan1,2; Yang, Ling3; Wang, Fuyi1,2 |
| 刊名 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
 |
| 出版日期 | 2014-04-01 |
| 卷号 | 77页码:110-120 |
| 关键词 | Ruthenium Complexes Egfr Inhibitors Multi-targeting Anticancer Agents Mcf-7 |
| ISSN号 | 0223-5234 |
| DOI | 10.1016/j.ejmech.2014.02.062 |
| 英文摘要 | The ruthenium DMSO complexes cis-(RuCl2)-Cl-II(DMO)(4) and [(DMSO)(2)H][trans-(RuCl4)-Cl-III(DMSO)(2)] reacted with 4-(3'-chloro-4'-fluoroanilino)-6-(2-(2-aminoethyl)aminoethoxy)-7-methoxyquinazoline (L1), 4-(3'chloro-4'-fluoroanilino)-6-(2-(1H-imidazol-1-yl)ethoxy)-7-methoxy quinazoline (L2), N-(benzo[d]imidazol-4-yl)-6,7-dimethoxyquinazolin-4-amine hydrochloride (L3), 5-(6,7-dimethoxyquinazolin-4-ylamino)quinolin-8-ol hydrochloride (L4), respectively, to afford [(RuCl2)-Cl-II(DMSO)(2)(L1)] (1), [(RuCl3)-Cl-III(DMSO)(L1)] (2), [(RuCl4)-Cl-III(DMSO)(H-L2)] (3), [(RuCl4)-Cl-III(DMSO)(H-L3)] (4), and [(RuCl3)-Cl-III(DMSO)(H-L4)] (5), which were characterised by mass spectrometry, NMR, elementary analysis and single crystal X-ray diffraction (complex 1). Experimental screening (ELISA) showed that complexes 1, 2 and 3 are remarkably inhibitory towards epidermal growth factor receptor (EGFR) with IC50 values at submicromolar or nanomolar level. Docking studies indicated that complexation with ruthenium has little interference with the formation of the two essential H-bonds between the N3 of the quinazoline ring in Ll and 12 and O-H of Thr766 through a water molecule, and the N1 of the quinazoline ring and N-H of Met769 in EGFR. Moreover, complex 2 was shown to be more active against the EGF-stimulated proliferation of human breast cancer cell line MCF-7 than the better EGFR inhibitor 4-(3'-chloro-4'-fluoroanilino)-6,7-dimethoxyquinazoline, being more potential to induce early-stage apoptosis than gefitinib. These imply that apart from inhibiting EGFR, complex 2 may involve in regulating other biological events related to the proliferation of MCF-7, implicating a novel type of multi-targeting metal-based anticancer agents. (C) 2014 Elsevier Masson SAS. All rights reserved. |
| 语种 | 英语 |
| WOS记录号 | WOS:000335874800013 |
| 出版者 | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER |
| 源URL | [http://ir.iccas.ac.cn/handle/121111/50351]  |
| 专题 | 中国科学院化学研究所 |
| 通讯作者 | Luo, Qun |
| 作者单位 | 1.Bing Natl Lab Mol Sci, Beijing, Peoples R China 2.Chinese Acad Sci, Inst Chem, CAS Key Lab Analyt Chem Living Biosyst, Beijing 100190, Peoples R China 3.Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian 116023, Peoples R China |
| 推荐引用方式 GB/T 7714 | Ji, Liyun,Zheng, Wei,Lin, Yu,et al. Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: Synthesis, characterisation and preliminary evaluation of biological activity[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2014,77:110-120. |
| APA | Ji, Liyun.,Zheng, Wei.,Lin, Yu.,Wang, Xiuli.,Lu, Shuang.,...&Wang, Fuyi.(2014).Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: Synthesis, characterisation and preliminary evaluation of biological activity.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,77,110-120. |
| MLA | Ji, Liyun,et al."Novel ruthenium complexes ligated with 4-anilinoquinazoline derivatives: Synthesis, characterisation and preliminary evaluation of biological activity".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 77(2014):110-120. |
入库方式： OAI收割
来源：化学研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。